Trial Profile

Clinical Trials Insight: 700047791

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 20 Aug 2010

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Bremelanotide (Primary)
Indications Erectile dysfunction
Focus Adverse reactions
Sponsors Palatin Technologies

Most Recent Events

17 Aug 2010 Status changed from active, no longer recruiting to completed, according to a Palatin Technologies media release.
24 Jun 2010 Top-line data are expected in the third quarter of 2010, according to a Palatin Technologies media release.
24 Jun 2010 Palatin Technologies completes patient dosing and database lock, according to a company media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com